Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Dunn

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
Psychology and Psychotherapy|April 21, 2022
The service user experience of SlowMo therapy: A co-produced thematic analysis of service users' subjective experienceKathryn E Greenwood, Megha Gurnani, Tom Ward, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
Journal of Mental Health (Abingdon, England)|December 23, 2017
Delivery of cognitive-behaviour therapy for psychosis: a service user preference trialGillian Haddock, Katherine Berry, Gabriel Davies, et al.
Schizophrenia Bulletin|July 18, 2014
How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoiaDaniel Freeman, Graham Dunn, Robin M Murray, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trialAnthony P Morrison, Paul French, Suzanne L K Stewart, et al.
The Lancet. Psychiatry|April 1, 2017
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trialIan M Anderson, Andrew Blamire, Tim Branton, et al.
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Psychology and Psychotherapy|April 21, 2022
The service user experience of SlowMo therapy: A co-produced thematic analysis of service users' subjective experienceKathryn E Greenwood, Megha Gurnani, Tom Ward, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
Journal of Mental Health (Abingdon, England)|December 23, 2017
Delivery of cognitive-behaviour therapy for psychosis: a service user preference trialGillian Haddock, Katherine Berry, Gabriel Davies, et al.
Schizophrenia Bulletin|July 18, 2014
How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoiaDaniel Freeman, Graham Dunn, Robin M Murray, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trialAnthony P Morrison, Paul French, Suzanne L K Stewart, et al.
The Lancet. Psychiatry|April 1, 2017
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trialIan M Anderson, Andrew Blamire, Tim Branton, et al.
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Pageof 21